Printer Friendly

Daiichi Products Covered by National Health Insurance.

Tokyo, Japan, Apr 5, 2006 - (JCN) - Some of Daiichi Pharmaceutical's Intrathecal Baclofen therapy products are now listed for national health insurance reimbursement. One of them is the SynchroMed infusion system that comprises of the SynchroMed EL pump and the InDura catheter.

Intrathecal Gabalon (baclofen) and the SynchroMed system are used to treat severe spasticity in patients if conventional treatments don't. The system involves a surgically implanted pump that automatically delivers baclofen directly to the spinal cord when needed.

Dosages delivered can be individually tailored are generally less than if taken orally. The SynchroMed system markedly reduces severe spasticity.

SynchroMed infusion and Intrathecal Gabalong have been used to treat some 50,000 patients worldwide.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Apr 5, 2006
Previous Article:Toyoda Gosei and Philips Lumileds Share LED Patents.
Next Article:Toray Launches Full-scale Commercialization of 'Ecodear' Polylactic Acid (PLA) Film.

Related Articles
CB Commercial selected.
Reckson inks long-term deal.
Daiichi Pharmaceutical Acquires Daiichi Suntory Pharma As Wholly Owned Subsidiary.
Daiichi Wins Lawsuit Against Mylan Pharmaceuticals Regarding Patents for Levofloxacin.
AnGes MG Unveils Future Development Strategies for HGF Gene Medicine.
Daiichi Pharmaceutical Korea to Become Wholly Owned Subsidiary of Daiichi Pharmaceutical.
Sanko Lifetech Transfers Animal Health Products Business to Novartis Animal Health.
Daiichi Sankyo Announces Completion of Phase I Trial on the Anti-influenza Drug CS-8958.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters